| E5O | Name: | 2-bromanyl-9-ethyl-~{N},~{N},7-trimethyl-3-thia-1$l^{4},5,6$l^{4},10-tetraza-2$l^{4}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(8),4,6,9,11-pentaen-4-amine | Formula: | C11 H16 Br Cu N5 S | SMILES: | CCc1ncc[n+]2c1C(=[N+]3N=C(S[Cu--]23Br)N(C)C)C | InChi: | InChI=1S/C11H17N5S.BrH.Cu/c1-5-9-10(13-7-6-12-9)8(2)14-15-11(17)16(3)4 | Definition date: | 2019-10-18 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | 2-bromanyl-9-ethyl-~{N},~{N},7-trimethyl-3-thia-1$l^{4},5,6$l^{4},10-tetraza-2$l^{4}-cupratricyclo[6.4.0.0^{2,6}]dodeca-1(8),4,6,9,11-pentaen-4-amine |
|
| EU9 | Name: | [(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[(3R)-3-azanyl-4-oxidanyl-4-oxidanylidene-butyl]-[(2-nitrophenyl)methyl]sulfanium | Formula: | C21 H26 N7 O7 S | SMILES: | N[CH](CC[S+](C[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23)Cc4ccccc4[N](=O)=O)C(O)=O | InChi: | InChI=1S/C21H25N7O7S/c22-12(21(31)32)5-6-36(7-11-3-1-2-4-13(11)28(33)34)8-14-16(29)17(30)20(35-14)27-10-26-15-18(23)24-9-25-19(15)27/h1-4,9-10,12,14,16-17,20,29-30H,5-8,22H2,(H2-,23,24,25,31,32)/p+1/t12-,14-,16-,17-,20-,36-/m1/s1 | Definition date: | 2020-01-24 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | [(2~{S},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-[(3~{R})-3-azanyl-4-oxidanyl-4-oxidanylidene-butyl]-[(2-nitrophenyl)methyl]sulfanium |
|
| I6P | Name: | INOSITOL 1,2,3,4,5,6-HEXAKISPHOSPHATE | Formula: | C6 H18 O24 P6 | SMILES: | O=P(OC1C(OP(=O)(O)O)C(OP(=O)(O)O)C(OP(=O)(O)O)C(OP(=O)(O)O)C1OP(=O)(O)O)(O)O | InChi: | InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/t1-,2-,3-,4+,5-,6- | Synonyms: | MYO-INOSITOL HEXAKISPHOSPHATE | Definition date: | 2010-03-31 | Last modified: | 2020-10-14 | Identifier: | (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexayl hexakis[dihydrogen (phosphate)] |
|
| UEY | Name: | 7-[(1R)-1,2-diphenylethyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine | Formula: | C19 H17 N5 | SMILES: | c4cccc(CC(c2cc(nc1c2nnn1)N)c3ccccc3)c4 | InChi: | InChI=1S/C19H17N5/c20-17-12-16(18-19(21-17)23-24-22-18)15(14-9-5-2-6-10-14)11-13-7-3-1-4-8-13/h1-10,12,15H,11H2,(H3,20,21,22,23,24)/t15-/m1/s1 | Definition date: | 2020-05-14 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 7-[(1R)-1,2-diphenylethyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine |
|
| UF7 | Name: | 7-[(1R)-1-phenyl-3-{[(1S,3S)-3-phenyl-2,3-dihydro-1H-inden-1-yl]amino}propyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine | Formula: | C29 H28 N6 | SMILES: | C3C(c1ccccc1)c2ccccc2C3NCCC(c4ccccc4)c5cc(N)nc6c5nnn6 | InChi: | InChI=1S/C29H28N6/c30-27-18-25(28-29(32-27)34-35-33-28)21(19-9-3-1-4-10-19)15-16-31-26-17-24(20-11-5-2-6-12-20)22-13-7-8-14-23(22)26/h1-14,18,21,24,26,31H,15-17H2,(H3,30,32,33,34,35)/t21-,24+,26+/m1/s1 | Definition date: | 2020-05-14 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 7-[(1R)-1-phenyl-3-{[(1S,3S)-3-phenyl-2,3-dihydro-1H-inden-1-yl]amino}propyl]-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine |
|
| V9D | Name: | N~1~,N~3~-dihydroxybenzene-1,3-dicarboxamide | Formula: | C8 H8 N2 O4 | SMILES: | C(=O)(NO)c1cccc(c1)C(NO)=O | InChi: | InChI=1S/C8H8N2O4/c11-7(9-13)5-2-1-3-6(4-5)8(12)10-14/h1-4,13-14H,(H,9,11)(H,10,12) | Definition date: | 2020-07-20 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | N~1~,N~3~-dihydroxybenzene-1,3-dicarboxamide |
|
| UFA | Name: | 7-{(1R)-1-phenyl-3-[(trans-4-phenylcyclohexyl)amino]propyl}-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine | Formula: | C26 H30 N6 | SMILES: | c1ccc(cc1)C(c3cc(nc2c3nnn2)N)CCNC4CCC(CC4)c5ccccc5 | InChi: | InChI=1S/C26H30N6/c27-24-17-23(25-26(29-24)31-32-30-25)22(20-9-5-2-6-10-20)15-16-28-21-13-11-19(12-14-21)18-7-3-1-4-8-18/h1-10,17,19,21-22,28H,11-16H2,(H3,27,29,30,31,32)/t19-,21-,22-/m1/s1 | Definition date: | 2020-05-14 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 7-{(1R)-1-phenyl-3-[(trans-4-phenylcyclohexyl)amino]propyl}-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine |
|
| UFD | Name: | 7-{(1R)-1-phenyl-3-[(4-phenylbicyclo[2.2.2]octan-1-yl)amino]propyl}-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine | Formula: | C28 H32 N6 | SMILES: | c1cccc(c1)C(c3cc(nc2nnnc23)N)CCNC64CCC(CC4)(c5ccccc5)CC6 | InChi: | InChI=1S/C28H32N6/c29-24-19-23(25-26(31-24)33-34-32-25)22(20-7-3-1-4-8-20)11-18-30-28-15-12-27(13-16-28,14-17-28)21-9-5-2-6-10-21/h1-10,19,22,30H,11-18H2,(H3,29,31,32,33,34)/t22-,27-,28+/m1/s1 | Definition date: | 2020-05-14 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 7-{(1R)-1-phenyl-3-[(4-phenylbicyclo[2.2.2]octan-1-yl)amino]propyl}-3H-[1,2,3]triazolo[4,5-b]pyridin-5-amine |
|
| U27 | Name: | 2-phenyl-N-{5-[(3R)-3-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide | Formula: | C24 H23 N7 O3 S2 | SMILES: | C5C(Oc1sc(nn1)NC(Cc2ccccc2)=O)CN(c4nnc(NC(Cc3ccccc3)=O)s4)C5 | InChi: | InChI=1S/C24H23N7O3S2/c32-19(13-16-7-3-1-4-8-16)25-21-27-29-23(35-21)31-12-11-18(15-31)34-24-30-28-22(36-24)26-20(33)14-17-9-5-2-6-10-17/h1-10,18H,11-15H2,(H,25,27,32)(H,26,28,33)/t18-/m1/s1 | Definition date: | 2019-10-10 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 2-phenyl-N-{5-[(3R)-3-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)pyrrolidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide |
|
| VD8 | Name: | 3,5-di~{tert}-butylbenzenesulfonamide | Formula: | C14 H23 N O2 S | SMILES: | CC(C)(C)c1cc(cc(c1)[S](N)(=O)=O)C(C)(C)C | InChi: | InChI=1S/C14H23NO2S/c1-13(2,3)10-7-11(14(4,5)6)9-12(8-10)18(15,16)17/h7-9H,1-6H3,(H2,15,16,17) | Definition date: | 2019-10-17 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 3,5-di~{tert}-butylbenzenesulfonamide |
|
| N8Z | Name: | 5-(4-chloranyl-1,5-dimethyl-pyrazol-3-yl)-4-ethyl-1,2,4-triazole-3-thiol | Formula: | C9 H12 Cl N5 S | SMILES: | CCn1c(S)nnc1c2nn(C)c(C)c2Cl | InChi: | InChI=1S/C9H12ClN5S/c1-4-15-8(11-12-9(15)16)7-6(10)5(2)14(3)13-7/h4H2,1-3H3,(H,12,16) | Definition date: | 2019-11-15 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 5-(4-chloranyl-1,5-dimethyl-pyrazol-3-yl)-4-ethyl-1,2,4-triazole-3-thiol |
|
| OHZ | Name: | 1-(3-Chloro-5-trifluoromethoxy-phenyl)-3-[2-(2-hydroxy-ethyl)-phenyl]-urea | Formula: | C16 H14 Cl F3 N2 O3 | SMILES: | OCCc1ccccc1NC(=O)Nc2cc(Cl)cc(OC(F)(F)F)c2 | InChi: | InChI=1S/C16H14ClF3N2O3/c17-11-7-12(9-13(8-11)25-16(18,19)20)21-15(24)22-14-4-2-1-3-10(14)5-6-23/h1-4,7-9,23H,5-6H2,(H2,21,22,24) | Synonyms: | 1-[3-chloranyl-5-(trifluoromethyloxy)phenyl]-3-[2-(2-hydroxyethyl)phenyl]urea | Definition date: | 2020-03-13 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 1-[3-chloranyl-5-(trifluoromethyloxy)phenyl]-3-[2-(2-hydroxyethyl)phenyl]urea |
|
| LTV | Name: | 2-hydroxy-3-(octadecanoyloxy)propyl pentacosanoate | Formula: | C46 H90 O5 | SMILES: | O=C(OCC(O)COC(=O)CCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCCCCCCCC | InChi: | InChI=1S/C46H90O5/c1-3-5-7-9-11-13-15-17-19-20-21-22-23-24-25-27-29-31-33-35-37-39-41-46(49)51-43-44(47)42-50-45(48)40-38-36-34-32-30-28-26-18-16-14-12-10-8-6-4-2/h44,47H,3-43H2,1-2H3/t44-/m0/s1 | Definition date: | 2019-03-13 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 2-hydroxy-3-(octadecanoyloxy)propyl pentacosanoate |
|
| NL8 | Name: | ~{N}-(4-aminocarbonylphenyl)-~{N}-methyl-2,4-bis(oxidanyl)benzamide | Formula: | C15 H14 N2 O4 | SMILES: | CN(C(=O)c1ccc(O)cc1O)c2ccc(cc2)C(N)=O | InChi: | InChI=1S/C15H14N2O4/c1-17(10-4-2-9(3-5-10)14(16)20)15(21)12-7-6-11(18)8-13(12)19/h2-8,18-19H,1H3,(H2,16,20) | Definition date: | 2019-12-06 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | ~{N}-(4-aminocarbonylphenyl)-~{N}-methyl-2,4-bis(oxidanyl)benzamide |
|
| MUE | Name: | naphthalene-2-sulfonamide | Formula: | C10 H9 N O2 S | SMILES: | N[S](=O)(=O)c1ccc2ccccc2c1 | InChi: | InChI=1S/C10H9NO2S/c11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10/h1-7H,(H2,11,12,13) | Definition date: | 2019-10-24 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | naphthalene-2-sulfonamide |
|
| LZW | Name: | (4~{S})-4-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1~{H}-cyclopenta[c]quinoline-8-sulfonamide | Formula: | C18 H18 N2 O3 S | SMILES: | N[S](=O)(=O)c1ccc2N[CH](C3=C(CCC3)c2c1)c4ccc(O)cc4 | InChi: | InChI=1S/C18H18N2O3S/c19-24(22,23)13-8-9-17-16(10-13)14-2-1-3-15(14)18(20-17)11-4-6-12(21)7-5-11/h4-10,18,20-21H,1-3H2,(H2,19,22,23)/t18-/m0/s1 | Definition date: | 2019-10-01 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | (4~{S})-4-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1~{H}-cyclopenta[c]quinoline-8-sulfonamide |
|
| NMW | Name: | [2,4-bis(oxidanyl)phenyl]-[(1~{S})-6,7-dimethoxy-1-pyridin-3-yl-3,4-dihydro-1~{H}-isoquinolin-2-yl]methanone | Formula: | C23 H22 N2 O5 | SMILES: | COc1cc2CCN([CH](c3cccnc3)c2cc1OC)C(=O)c4ccc(O)cc4O | InChi: | InChI=1S/C23H22N2O5/c1-29-20-10-14-7-9-25(23(28)17-6-5-16(26)11-19(17)27)22(15-4-3-8-24-13-15)18(14)12-21(20)30-2/h3-6,8,10-13,22,26-27H,7,9H2,1-2H3/t22-/m1/s1 | Definition date: | 2019-12-06 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | [2,4-bis(oxidanyl)phenyl]-[(1~{S})-6,7-dimethoxy-1-pyridin-3-yl-3,4-dihydro-1~{H}-isoquinolin-2-yl]methanone |
|
| NN8 | Name: | [2,4-bis(oxidanyl)phenyl]-[(1~{R})-6,7-dimethoxy-1-pyridin-3-yl-3,4-dihydro-1~{H}-isoquinolin-2-yl]methanone | Formula: | C23 H22 N2 O5 | SMILES: | COc1cc2CCN([CH](c3cccnc3)c2cc1OC)C(=O)c4ccc(O)cc4O | InChi: | InChI=1S/C23H22N2O5/c1-29-20-10-14-7-9-25(23(28)17-6-5-16(26)11-19(17)27)22(15-4-3-8-24-13-15)18(14)12-21(20)30-2/h3-6,8,10-13,22,26-27H,7,9H2,1-2H3/t22-/m0/s1 | Definition date: | 2019-12-06 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | [2,4-bis(oxidanyl)phenyl]-[(1~{R})-6,7-dimethoxy-1-pyridin-3-yl-3,4-dihydro-1~{H}-isoquinolin-2-yl]methanone |
|
| MHK | Name: | naphthalene-1-sulfonamide | Formula: | C10 H9 N O2 S | SMILES: | N[S](=O)(=O)c1cccc2ccccc12 | InChi: | InChI=1S/C10H9NO2S/c11-14(12,13)10-7-3-5-8-4-1-2-6-9(8)10/h1-7H,(H2,11,12,13) | Definition date: | 2019-10-15 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | naphthalene-1-sulfonamide |
|
| MJT | Name: | anthracene-9-sulfonamide | Formula: | C14 H11 N O2 S | SMILES: | N[S](=O)(=O)c1c2ccccc2cc3ccccc13 | InChi: | InChI=1S/C14H11NO2S/c15-18(16,17)14-12-7-3-1-5-10(12)9-11-6-2-4-8-13(11)14/h1-9H,(H2,15,16,17) | Definition date: | 2019-10-16 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | anthracene-9-sulfonamide |
|
| MKQ | Name: | 3,5-diphenylbenzenesulfonamide | Formula: | C18 H15 N O2 S | SMILES: | N[S](=O)(=O)c1cc(cc(c1)c2ccccc2)c3ccccc3 | InChi: | InChI=1S/C18H15NO2S/c19-22(20,21)18-12-16(14-7-3-1-4-8-14)11-17(13-18)15-9-5-2-6-10-15/h1-13H,(H2,19,20,21) | Definition date: | 2019-10-17 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 3,5-diphenylbenzenesulfonamide |
|
| Q9M | Name: | 2-phenyl-N-{5-[(1-{5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}azetidin-3-yl)oxy]-1,3,4-thiadiazol-2-yl}acetamide | Formula: | C23 H21 N7 O3 S2 | SMILES: | C3(CN(c2sc(NC(Cc1ccccc1)=O)nn2)C3)Oc5nnc(NC(=O)Cc4ccccc4)s5 | InChi: | InChI=1S/C23H21N7O3S2/c31-18(11-15-7-3-1-4-8-15)24-20-26-28-22(34-20)30-13-17(14-30)33-23-29-27-21(35-23)25-19(32)12-16-9-5-2-6-10-16/h1-10,17H,11-14H2,(H,24,26,31)(H,25,27,32) | Definition date: | 2019-10-08 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 2-phenyl-N-{5-[(1-{5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}azetidin-3-yl)oxy]-1,3,4-thiadiazol-2-yl}acetamide |
|
| QA4 | Name: | 2-cyclopropyl-N-{5-[4-({5-[(cyclopropylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide | Formula: | C19 H25 N7 O3 S2 | SMILES: | N(C(CC1CC1)=O)c5nnc(OC4CCN(c2sc(nn2)NC(CC3CC3)=O)CC4)s5 | InChi: | InChI=1S/C19H25N7O3S2/c27-14(9-11-1-2-11)20-16-22-24-18(30-16)26-7-5-13(6-8-26)29-19-25-23-17(31-19)21-15(28)10-12-3-4-12/h11-13H,1-10H2,(H,20,22,27)(H,21,23,28) | Definition date: | 2019-10-09 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 2-cyclopropyl-N-{5-[4-({5-[(cyclopropylacetyl)amino]-1,3,4-thiadiazol-2-yl}oxy)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide |
|
| QAA | Name: | 2-phenyl-N-{6-[4-({6-[(phenylacetyl)amino]pyridazin-3-yl}oxy)piperidin-1-yl]pyridazin-3-yl}acetamide | Formula: | C29 H29 N7 O3 | SMILES: | c1cc(nnc1NC(Cc2ccccc2)=O)OC5CCN(c3nnc(cc3)NC(=O)Cc4ccccc4)CC5 | InChi: | InChI=1S/C29H29N7O3/c37-27(19-21-7-3-1-4-8-21)30-24-11-13-26(34-32-24)36-17-15-23(16-18-36)39-29-14-12-25(33-35-29)31-28(38)20-22-9-5-2-6-10-22/h1-14,23H,15-20H2,(H,30,32,37)(H,31,33,38) | Definition date: | 2019-10-09 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 2-phenyl-N-{6-[4-({6-[(phenylacetyl)amino]pyridazin-3-yl}oxy)piperidin-1-yl]pyridazin-3-yl}acetamide |
|
| QAJ | Name: | 2-(pyridin-3-yl)-N-(5-{4-[(5-{[(pyridin-3-yl)acetyl]amino}-1,3,4-thiadiazol-2-yl)amino]piperidin-1-yl}-1,3,4-thiadiazol-2-yl)acetamide | Formula: | C23 H24 N10 O2 S2 | SMILES: | N1(CCC(CC1)Nc3nnc(NC(Cc2cccnc2)=O)s3)c4sc(nn4)NC(=O)Cc5cccnc5 | InChi: | InChI=1S/C23H24N10O2S2/c34-18(11-15-3-1-7-24-13-15)27-21-30-29-20(36-21)26-17-5-9-33(10-6-17)23-32-31-22(37-23)28-19(35)12-16-4-2-8-25-14-16/h1-4,7-8,13-14,17H,5-6,9-12H2,(H,26,29)(H,27,30,34)(H,28,31,35) | Definition date: | 2019-10-10 | Last modified: | 2020-10-09 | Release date: | 2020-10-14 | Identifier: | 2-(pyridin-3-yl)-N-(5-{4-[(5-{[(pyridin-3-yl)acetyl]amino}-1,3,4-thiadiazol-2-yl)amino]piperidin-1-yl}-1,3,4-thiadiazol-2-yl)acetamide |
|